234 related articles for article (PubMed ID: 30767755)
1. Nanocarriers For Vaginal Drug Delivery.
Iqbal Z; Dilnawaz F
Recent Pat Drug Deliv Formul; 2019; 13(1):3-15. PubMed ID: 30767755
[TBL] [Abstract][Full Text] [Related]
2. Nano-sized platforms for vaginal drug delivery.
El-Hammadi MM; Arias JL
Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
[TBL] [Abstract][Full Text] [Related]
3. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery.
Taurin S; Almomen AA; Pollak T; Kim SJ; Maxwell J; Peterson CM; Owen SC; Janát-Amsbury MM
J Drug Target; 2018 Aug; 26(7):533-550. PubMed ID: 29096548
[TBL] [Abstract][Full Text] [Related]
5. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-based drug delivery to the vagina: a review.
Ensign LM; Cone R; Hanes J
J Control Release; 2014 Sep; 190():500-14. PubMed ID: 24830303
[TBL] [Abstract][Full Text] [Related]
7. Polymer-based nanocarriers for vaginal drug delivery.
das Neves J; Nunes R; Machado A; Sarmento B
Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
Pathak K; Akhtar N
Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides.
Sánchez-López E; Gómara MJ; Haro I
Curr Med Chem; 2021; 28(22):4356-4379. PubMed ID: 33297908
[TBL] [Abstract][Full Text] [Related]
10. Anticancer drug delivery with nanoparticles.
Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
[TBL] [Abstract][Full Text] [Related]
11. Exploring novel approaches to vaginal drug delivery.
Gupta S; Gabrani R; Ali J; Dang S
Recent Pat Drug Deliv Formul; 2011 May; 5(2):82-94. PubMed ID: 21413924
[TBL] [Abstract][Full Text] [Related]
12. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
14. The Know-how of Polymeric Nanocarrier Based Vaginal Drug Delivery System: Pitfalls, Challenges and Trends.
Kanojiya P; Wadetwar R; Karemore M; Prasad S
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38279713
[TBL] [Abstract][Full Text] [Related]
15. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.
Krogstad EA; Ramanathan R; Nhan C; Kraft JC; Blakney AK; Cao S; Ho RJY; Woodrow KA
Biomaterials; 2017 Nov; 144():1-16. PubMed ID: 28802690
[TBL] [Abstract][Full Text] [Related]
17. Nose-to-brain peptide delivery - The potential of nanotechnology.
Samaridou E; Alonso MJ
Bioorg Med Chem; 2018 Jun; 26(10):2888-2905. PubMed ID: 29170026
[TBL] [Abstract][Full Text] [Related]
18. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
